A Wealth of Experience

We have collaborated with our clients on projects to research hematology, hematologic treatments, and complications and comorbidities of hematologic diseases. Our experience includes:

  • Allogeneic cord blood therapy 
  • Anemia
  • Blood transfusions
  • Hemophilia A
  • Hemophilia B
  • Myelofibrosis
  • Neutropenia
  • Polycythemia Vera
  • Pulmonary and venous embolism
  • Thrombocytopenia

Types of Projects

We have implemented studies to help our clients develop strategies in the hematology market and to develop and gain 
market access for products to treat hematologic diseases and complications arising from treatment of hematologic diseases.

Recent projects have included:

Our Experts

Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
Xiaolei Zhou
Director, Biostatistics
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Sorrel Wolowacz
Head, European Health Economics
Keith Davis
Senior Director, Health Economics
William L Herring
Senior Director, Health Economics
Lia Gutierrez
Senior Director, Epidemiology
Joan Fortuny
Director, Epidemiology
Alicia Gilsenan
Vice President, Epidemiology
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Annete Njue
Senior Director, Market Access and Outcomes Strategy
James Kaye
Senior Director, Epidemiology
Chris Knight
Senior Director, Health Economics

Selected Recent Hematology Publications